tiprankstipranks
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA

Atara Biotherapeutics (ATRA) Financial Statements

1,021 Followers

Atara Biotherapeutics Financial Overview

Atara Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-2.774; its P/E ratio is -0.24; Atara Biotherapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 2.14M$ 957.00K--$ 4.46M
Gross Profit$ 4.75M$ 957.00K---
EBIT$ -68.42M$ -69.73M$ -73.41M$ -74.32M$ -84.62M
EBITDA$ -67.21M$ -68.53M$ -72.20M$ -75.62M$ -83.25M
Net Income Common Stockholders$ -64.57M$ -71.11M$ -74.77M$ -74.55M$ -84.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 102.41M$ 153.79M$ 205.55M$ 242.97M$ 265.40M
Total Assets$ 188.79M$ 246.44M$ 302.08M$ 376.42M$ 368.32M
Total Debt$ 48.51M$ 51.75M$ 54.92M$ 58.06M$ 61.07M
Net Debt$ -53.90M$ -102.03M$ -150.63M$ -184.90M$ -204.33M
Total Liabilities$ 239.63M$ 238.99M$ 237.12M$ 249.78M$ 181.20M
Stockholders Equity$ -50.84M$ 7.45M$ 64.96M$ 126.64M$ 187.11M
Cash Flow-
Free Cash Flow$ -51.60M$ -53.30M$ -38.83M$ -56.92M$ -65.19M
Operating Cash Flow$ -51.35M$ -52.80M$ -38.43M$ -56.88M$ -65.06M
Investing Cash Flow$ 70.45M$ 49.48M$ -6.01M$ 51.22M$ 59.70M
Financing Cash Flow$ -208.00K$ 471.00K$ 235.00K$ 32.29M$ -214.00K
Currency in USD

Atara Biotherapeutics Earnings and Revenue History

Atara Biotherapeutics Debt to Assets

Atara Biotherapeutics Cash Flow

Atara Biotherapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis